CURRENT STRATEGIES IN THE DIAGNOSIS AND MANAGEMENT OF LOWER-EXTREMITY PERIPHERAL VASCULAR-DISEASE

被引:27
作者
WILT, TJ
机构
[1] Section of General Internal Medicine (111-0), Minneapolis Veterans Affairs Medical Center, Minneapolis, 55417, MN
关键词
D O I
10.1007/BF02599110
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:87 / 101
页数:15
相关论文
共 108 条
[91]  
Jones N.A.G., DeHaas H., Zahavi J., Kakkar V.V., A double-blind trial of suloctidil v placebo in intermittent claudication, Br J Surg, 69, pp. 38-40, (1982)
[92]  
Katsumura T., Mishima Y., Kamiya K., Sakaguchi S., Tanabe T., Sakuma A., Therapeutic effect of ticlopidine, a new inhibitor of platelet aggregation on chronic arterial occlusive disease, a double-blind study versus placebo, Angiology, 33, (1982)
[93]  
Hess H., Miewtaschik A., Deischsel G., Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease
[94]  
a prospective double-blind arteriographically controlled trial, Lancet, 1, pp. 415-19, (1985)
[95]  
Secondary prevention of vascular disease by prolonged antiplatelet treatment, Br Med J, 296, pp. 320-3, (1988)
[96]  
Preliminary report: findings from the aspirin component of the ongoing physicians’ health study, N Engl J Med, 318, pp. 262-64, (1988)
[97]  
Peto R., Gray R., Collins R., Et al., Randomized trial of prophylactic daily aspirin in British male doctors, Br Med J, 296, pp. 313-16, (1988)
[98]  
Bounameaux H., Holditch T., Hellemans H., Et al., Placebo-controlled double-blind two-centre trial of ketanserin in intermittent claudication, Lancet, 2, 8467, (1985)
[99]  
Leaf A., Weber P.C., Cardiovascular effects of n-3 fatty acids, N Engl J Med, 318, pp. 549-57, (1988)
[100]  
Jeans W.D., Danton R.M., Baird R.N., Horrocks M., The effects of introducing balloon dilatation into vascular surgical practice, Br J Radiol, 59, pp. 457-9, (1986)